Gilead partners with various organizations that support people living with breast cancer. One such organization, the Young Survival Coalition (YSC), recognizes the unique needs of people of childbearing age and works with patients under 40.
The personal journeys of six people in the United Kingdom living with HIV, hepatitis C and cancer – and the challenges they face due to stigma and health inequities – come together in the form of a new, intentionally difficult-to-read book from Gilead.
Responsible Business & Employee Engagement
| Gilead Sciences
When employees at Gilead’s recently opened New Jersey office need a place to meet, the “Cara” conference room is one such place they gather. Given the room’s namesake, it’s especially fitting when the topic at hand is the company’s oncology work.
Since the beginning of the COVID-19 pandemic, Gilead’s first-in-class antiviral was made available to more than 11 million patients globally– over 65% of whom live in low-and lower-middle-income countries.
Before Rashad Burgess held the professional title of Vice President of Advancing Health and Equity at Gilead Sciences or the personal identification of husband and father
Alonzo Henderson is the Media, Communications and Technical Assistant for Kingmakers of Oakland, a nonprofit dedicated to improving the lives of Black youth in public school systems.
Kelly was getting ready to leave on a trip to celebrate her 25th wedding anniversary when she started experiencing pain in her abdomen and discovered a lump on her neck.
“For me, meeting my peers, women who were living with HIV and who also had children – that was a turning point for me,” Angelina says. “I needed that kind of support. It really helped me to cope back then.”
Gilead Sciences, Inc. (Nasdaq: GILD) today announced a new health equity collaboration with the Satcher Health Leadership Institute (SHLI) at Morehouse School of Medicine and the Center for
We connected with Jared Baeten, Gilead’s Vice President of HIV Clinical Development to discuss the top highlights from AIDS 2022, and ways the company is looking to help transform care and improve outcomes for people affected by HIV.
Pharma’s reputation may have soared amid the pandemic, but that came with a brighter spotlight on diversity, equity and inclusion issues. In recent years, pharma has been trying to incorporate DEI more deeply into its corporate psyche.
Gilead’s Corporate Social Responsibility (CSR) Report provides an overview of the work the company is doing around the world to improve the lives of...